State Street’s Bright Minds Biosciences DRUG Stock Holding History

State Street’s Portfolio DRUG Stock Details DRUG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.58M	Buy	122,178 +13,939	+13%	+$1.09M	﹤0.01%	2807
2026 Q1	$7.9M	Buy	108,239 +30,961	+40%	+$2.49M	﹤0.01%	2736
2025 Q4	$6.03M	Buy	77,278 +8,890	+13%	+$594K	﹤0.01%	2904
2025 Q3	$4.15M	Buy	68,388 +43,733	+177%	+$1.7M	﹤0.01%	3063
2025 Q2	$644K	Buy	+24,655	New	+$739K	﹤0.01%	3569

Other funds holding DRUG

Jupiter Topco New York $245B AUM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State Street's DRUG Position: Q2 2026 in Review

State Street increased its Bright Minds Biosciences (DRUG) stake by 13% in Q2 2026, buying an estimated $1.09M and bringing the position to 122,178 shares worth $8.58M. The position accounts for ﹤0.01% of the portfolio, ranked #2807.

State Street first reported a position in DRUG in Q2 2025 and has held it in 5 quarters since. 99 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

State Street held 122,178 shares of Bright Minds Biosciences worth $8.58M as of Q2 2026.
State Street bought 13,939 Bright Minds Biosciences shares in Q2 2026, an estimated $1.09M.
Bright Minds Biosciences made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2807 holding.
State Street first reported a position in Bright Minds Biosciences in Q2 2025 and has held it in 5 quarters since.
99 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.